<ѻýҕl>Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Eventsѻýҕl> Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
<ѻýҕl>Tranexamic Acid Cuts Surgical Bleeding in Yet Another Settingѻýҕl> But POISE-3 trial leaves open the question of cardiovascular safety Apr 02, 2022
<ѻýҕl>From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classesѻýҕl> Update also adds SGLT2 inhibitor as a pillar of therapy Apr 01, 2022
<ѻýҕl>In-Person ACC Meeting Returns, Serving Diet Intervention Studies and Moreѻýҕl> Will salt restriction finally get a boost at this weekend's meeting? Mar 31, 2022
<ѻýҕl>Xarelto Flops for COVID-19 Clot Prevention Outside ICUѻýҕl> ACTION trial adds nuance to the story from large platform trials May 19, 2021
<ѻýҕl>Burnout in Cardiology; Restrictive Transfusion Foiled; and Other News From ACCѻýҕl> Highlights from the scientific program of the American College of Cardiology meeting May 18, 2021
<ѻýҕl>Setbacks for Invasive Strategy, Moderate Cooling in Cardiac Arrestѻýҕl> Prague OHCA study, CAPITAL CHILL give some answers for out-of-hospital cardiac arrest treatment May 18, 2021
<ѻýҕl>Falling Through the Cracks on Rapid Troponin Testing Protocolsѻýҕl> Studies point to potential risks and pitfalls with change to more sensitive, rapid testing May 18, 2021
<ѻýҕl>Novel Heart Failure Agent Works Best in Sickest Patientsѻýҕl> Omecamtiv mecarbil provides benefit to those with low LVEF May 18, 2021
<ѻýҕl>Plavix Beats Aspirin, Brilinta After Stentingѻýҕl> HOST-EXAM and TALOS-AMI studies from South Korea focus on aspects of DAPT May 18, 2021
<ѻýҕl>Finerenone May Delay AFib Onset in Patients With CKD and Diabetesѻýҕl> Risk of kidney or CV events reduced regardless of atrial fibrillation or atrial flutter history May 18, 2021
<ѻýҕl>Entresto Risky for Advanced Heart Failure?ѻýҕl> LIFE trial "not only disappointed but surprised" with its findings May 17, 2021
<ѻýҕl>Stubborn Gaps in Heart Failure Persist Despite Clinician Education, Feedbackѻýҕl> Guideline-directed medical therapy underuse still a problem in CONNECT-HF trial May 17, 2021
<ѻýҕl>Antifibrotic Drug Shows Promise in HFpEFѻýҕl> PIROUETTE trial provides early proof May 17, 2021
<ѻýҕl>Personalized Rehab Helpful in Heart Failure Patientsѻýҕl> Trial showed improvements in physical functioning and quality of life compared with usual care May 17, 2021
<ѻýҕl>DARE-19 Didn't Pay Off for Farxiga in COVID-19ѻýҕl> But trial may still show SGLT2 inhibitor is safe for sicker patients May 17, 2021
<ѻýҕl>Renal Denervation Shows Worth in Resistant Hypertensionѻýҕl> Catheter-based procedure gets a win in RADIANCE-HTN TRIO May 16, 2021
<ѻýҕl>A Call for Nuance in Cardioprotection With Early Breast Cancer Therapyѻýҕl> Longer-term PRADA trial results weigh in for low-risk group May 16, 2021
<ѻýҕl>FFR Disappoints as Guide for PCI on Non-Culprit Lesions in STEMIѻýҕl> Angiography-guided strategy holds strong in FLOWER-MI trial May 16, 2021
<ѻýҕl>LAA Occlusion During Surgery Cuts Stroke Riskѻýҕl> Afib patients on antithrombotic therapy saw gains from add-on left atrial appendage occlusion May 16, 2021
<ѻýҕl>Baby Aspirin on Par With Full Dose to Prevent Repeat Heart Eventsѻýҕl> But landmark trial was hampered by crossover May 15, 2021
<ѻýҕl>Strategy of DOAC After TAVR Disappoints in ATLANTISѻýҕl> Is aspirin alone still best after transcatheter aortic valve replacement? May 15, 2021
<ѻýҕl>Mixed Results with ARNI Therapy for Post-MI Heart Failure Preventionѻýҕl> Sacubitril/valsartan deemed safe, but still can't beat ramipril in PARADISE-MI trial May 15, 2021
<ѻýҕl>Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathyѻýҕl> Secondary findings show big gains for more than a third of patients May 15, 2021
<ѻýҕl>ARNI Therapy in the Hot Seat at Another Virtual ACCѻýҕl> PARADISE-MI to provide data on Entresto for MI survivors with reduced LVEF May 14, 2021
<ѻýҕl>ISCHEMIA Trial Puts Big Question Mark on Implications of Ischemiaѻýҕl> Subanalyses of the landmark trial show lack of correlation to outcomes Apr 01, 2020
<ѻýҕl>Mavacamten Promising in Non-Obstructive HCMѻýҕl> Phase II MAVERICK-HCM trial looked at safety, efficacy of myosin inhibitor Apr 01, 2020
<ѻýҕl>DAPT Plus DOAC a Loser After Lower Limb Revascularizationѻýҕl> Three drugs post-procedure is one too many, study suggests Apr 01, 2020
<ѻýҕl>Homozygous FH Falls to Praluent, Novel Agentѻýҕl> Drugs succeed in cutting LDL in extra-refractory form of high cholesterol Mar 31, 2020
<ѻýҕl>Higher On-Tx EPA Levels Explain Benefit of Vascepaѻýҕl> Further evidence from REDUCE-IT that triglyceride lowering is not key to icosapent ethyl's effects Mar 30, 2020
<ѻýҕl>TWILIGHT Findings Hold Strong in Diabetes, Complex PCIѻýҕl> Ticagrelor monotherapy after brief DAPT also worked following newer-gen stent implantation Mar 30, 2020
<ѻýҕl>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleedsѻýҕl> Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<ѻýҕl>More 'Convincing' Data on BP Drop After Renal Denervationѻýҕl> Full results reported from SPYRAL HTN-OFF MED Mar 29, 2020
<ѻýҕl>TAVR: Promising in Low-Risk Patients With Bicuspid Anatomyѻýҕl> However, pacemaker rate still high in experienced hands, according to early data Mar 29, 2020
<ѻýҕl>AFib Patients Better Off With No Antiplatelet After TAVRѻýҕl> POPular TAVI trial supports sticking to anticoagulation alone Mar 29, 2020
<ѻýҕl>Favorable Results for DOAC After Peripheral Interventionѻýҕl> But the devil's in the details of the VOYAGER PAD trial, expert opines Mar 28, 2020
<ѻýҕl>Vericiguat Cuts Admissions in HFrEFѻýҕl> VICTORIA trial dubbed a "win" for novel agent Mar 28, 2020
<ѻýҕl>Radial vs Femoral; P2Y12 Inhibitor Monotherapy; PCI With Microbubblesѻýҕl> Advances in interventional cardiology at ACC 2019 Mar 20, 2019
<ѻýҕl>Bempedoic Acid: Modest LDL Lowering Affirmedѻýҕl> CLEAR Wisdom completes the phase III picture; next step, FDA review Mar 20, 2019